Association of common gene variants in vitamin D modulating genes and colon cancer recurrence.

J Cancer Res Clin Oncol 2013 Sep 23;139(9):1457-64. Epub 2013 Jun 23.

Division of Clinical Oncology, Department of Medicine, Medical University of Graz, Graz, Austria.

Purpose: Low concentrations of 25-hydroxyvitamin D3 (25(OH)D) have been associated with increased risk and poor prognosis of various cancer types, including colon cancer. Common genetic variants in genes that influence circulating 25(OH)D levels may affect vitamin D concentrations and risk of vitamin D insufficiency. In the present study, we investigated the association of three functional gene variants in GC (rs2282679 T>G), DHCR7 (rs12785878 G>T) and CYP2R1 (rs10741657 A>G) with time to recurrence (TTR) in patients with stages II and III colon cancer.

Methods: Two hundred and sixty-four patients were included in this retrospective study. Genomic DNA was genotyped for GC rs2282679 T>G, DHCR7 rs12785878 G>T and CYP2R1 rs10741657 A>G by 5'-exonuclease (TaqMan™) technology.

Results: In the univariate analysis, GC rs2282679 GG was significantly associated with decreased TTR (HR = 3.30, 95 % CI 1.09-9.97, p = 0.034) in patients with surgery alone and remained significantly associated in multivariate analysis including lymph node involvement and clinical stage (HR = 3.64, 95 % CI 1.16-11.46, p = 0.027). In patients with adjuvant chemotherapy, GC rs2282679 T>G was not significantly associated with TTR (HR = 1.02, 95 % CI 0.44-2.37, p = 0.964). Furthermore, we observed a trend toward decreased TTR in patients harboring the CYP2R1 rs10741657 A>G gene variant including all patients (HR = 1.50, 95 % CI 0.98-2.28, p = 0.060). No association was found between DHCR7 rs12785878 G>T and TTR in our study cohort.

Conclusion: In conclusion, our results may indicate a prognostic effect of GC rs2282679 in stages II and III colon cancer patients with surgery alone. Larger studies have to be performed to validate our findings.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00432-013-1461-xDOI Listing
September 2013
14 Reads

Publication Analysis

Top Keywords

cyp2r1 rs10741657
12
rs12785878 g>t
12
dhcr7 rs12785878
12
rs2282679 t>g
12
rs10741657 a>g
12
colon cancer
12
decreased ttr
8
ttr patients
8
gene variants
8
g>t cyp2r1
8
iii colon
8
stages iii
8
patients surgery
8
t>g dhcr7
8
patients
7
ttr
5
rs2282679
5
95 % 109-997
4
associated decreased
4
ttr hr = 330
4

References

(Supplied by CrossRef)

J Ahn et al.
Hum Mol Genet 2010

MH Ahonen et al.
Cancer Causes Control 2000

P Bareis et al.
Biochem Biophys Res Commun 2001

M Ben-Shoshan et al.
Mol Cancer Ther 2007

G Bises et al.
J Histochem Cytochem 2004

P Boyle et al.
Ann Oncol 2005

JB Cheng et al.
Proc Natl Acad Sci USA 2004

HS Cross et al.
Steroids 2001

Y Cui et al.
Cancer Epidemiol Biomarkers Prev 2006

KK Deeb et al.
Nat Rev Cancer 2007

GD Díaz et al.
Cancer Res 2000

Similar Publications